News

Thirty nurses from University of Maryland Medical System-affiliated hospitals have been named as "Excellence in Nursing" winners by Baltimore Magazine.

The following statement is in response to media questions about allegations against former UMMC employee Matthew Bathula.  

Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every year with one in five cases occurring in people younger than 55, according to the American Cancer Society. A new study provides insights that may eventually help oncologists better predict how the disease will respond to certain therapies, leading to improved survival outcomes for patients.

A new $10.8 million multicenter clinical trial co-led by Gerard Slobogean, MD, MPH, an orthopaedic trauma surgeon at the R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center (UMMC), will determine if hip replacement surgery, also known as hip arthroplasty, produces better outcomes for patients ages 60 and older than simpler “internal fixation” that has been performed for decades. 

A new $10.8 million multicenter clinical trial co-led by Gerard Slobogean, MD, MPH, an orthopaedic trauma surgeon at the R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center (UMMC), will determine if hip replacement surgery, also known as hip arthroplasty, produces better outcomes for patients ages 60 and older than simpler “internal fixation” that has been performed for decades. 

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) Executive Director, Taofeek K. Owonikoko, MD, PhD, and University of Maryland School of Medicine (UMSOM) Department of Surgery Chair, Christine Lau, MD, MBA, have announced that Jeremy L. Davis, MD, has been appointed the new Surgical Oncology Lead for UMGCCC and Chief of the Division of Surgical Oncology in the Department of Surgery at UMSOM. Dr. Davis is a nationally recognized surgical oncologist and leader in gastric cancer research. He started in his new roles at the end of last month.

Researchers at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) are conducting a first-in-human clinical trial of a novel next-generation CAR T-cell therapy to treat patients with recurrent or difficult-to-treat B-cell lymphomas, which are cancers of the lymphatic system.

The R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center (UMMC) hosted its 34th annual Shock Trauma Heroes Celebration tonight, honoring more than 80 trauma professionals and first responders who provided lifesaving care to two critically injured patients.